Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Engelhardt

Showing results (201-210 of 255) with videos related to

Pageof 26
Sort By:
Blood|January 21, 2012
Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivityBrian G Engelhardt, Shubhada M Jagasia, James E Crowe, et al.
Breast (Edinburgh, Scotland)|March 3, 2020
The impact of patient characteristics and lifestyle factors on the risk of an ipsilateral event after a primary DCIS: A systematic reviewSena Alaeikhanehshir, Ellen G Engelhardt, Frederieke H van Duijnhoven, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 28, 2019
Needs with Regard to Decision Support Systems for Treating Patients with Incurable Non-small Cell Lung CancerDóra Révész, Ellen G Engelhardt, Johannes J Tamminga, et al.
Breast (Edinburgh, Scotland)|July 27, 2025
Prognostication and treatment predictions for estrogen receptor positive early-stage breast cancer: incorporating the 70-gene signature into the PREDICT prognostication modelEllen G Engelhardt, Mary Ann E Binuya, Paul D P Pharoah, et al.
Annals of Surgical Oncology|February 1, 2025
Risk-Prediction Models for Clinical Decision-Making in Sarcoma Care: An International Survey Among Soft-Tissue Sarcoma CliniciansAnouk A Kruiswijk, Lisa A E Vlug, Ibtissam Acem, et al.
Plos One|February 9, 2018
Prediction models for patients with esophageal or gastric cancer: A systematic review and meta-analysisH G van den Boorn, E G Engelhardt, J van Kleef, et al.
Transplantation and Cellular Therapy|March 11, 2023
TP53 Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid LeukemiaJennifer Marvin-Peek, Emily F Mason, Ashwin Kishtagari, et al.
Bone Marrow Transplantation|January 30, 2020
Minimal residual disease negativity and lenalidomide maintenance therapy are associated with superior survival outcomes in multiple myelomaDilan A Patel, Ragisha Gopalakrishnan, Brian G Engelhardt, et al.
Cytotherapy|September 3, 2013
New allergies after cord blood transplantationLeigh Ann Vaughan, Mary Vu, Salyka Sengsayadeth, et al.
Annals of Surgical Oncology|April 16, 2025
ASO Visual Abstract: Use of Risk-Prediction Models (RPMs) for Clinical Decision Making in Soft-Tissue Sarcomas in the Extremities (eSTS): A Survey StudyAnouk A Kruiswijk, Lisa A E Vlug, Ibtissam Acem, et al.
Pageof 26

Showing results (201-210 of 255) with videos related to

Sort By:
Pageof 26
Blood|January 21, 2012
Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivityBrian G Engelhardt, Shubhada M Jagasia, James E Crowe, et al.
Breast (Edinburgh, Scotland)|March 3, 2020
The impact of patient characteristics and lifestyle factors on the risk of an ipsilateral event after a primary DCIS: A systematic reviewSena Alaeikhanehshir, Ellen G Engelhardt, Frederieke H van Duijnhoven, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 28, 2019
Needs with Regard to Decision Support Systems for Treating Patients with Incurable Non-small Cell Lung CancerDóra Révész, Ellen G Engelhardt, Johannes J Tamminga, et al.
Breast (Edinburgh, Scotland)|July 27, 2025
Prognostication and treatment predictions for estrogen receptor positive early-stage breast cancer: incorporating the 70-gene signature into the PREDICT prognostication modelEllen G Engelhardt, Mary Ann E Binuya, Paul D P Pharoah, et al.
Annals of Surgical Oncology|February 1, 2025
Risk-Prediction Models for Clinical Decision-Making in Sarcoma Care: An International Survey Among Soft-Tissue Sarcoma CliniciansAnouk A Kruiswijk, Lisa A E Vlug, Ibtissam Acem, et al.
Plos One|February 9, 2018
Prediction models for patients with esophageal or gastric cancer: A systematic review and meta-analysisH G van den Boorn, E G Engelhardt, J van Kleef, et al.
Transplantation and Cellular Therapy|March 11, 2023
TP53 Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid LeukemiaJennifer Marvin-Peek, Emily F Mason, Ashwin Kishtagari, et al.
Bone Marrow Transplantation|January 30, 2020
Minimal residual disease negativity and lenalidomide maintenance therapy are associated with superior survival outcomes in multiple myelomaDilan A Patel, Ragisha Gopalakrishnan, Brian G Engelhardt, et al.
Cytotherapy|September 3, 2013
New allergies after cord blood transplantationLeigh Ann Vaughan, Mary Vu, Salyka Sengsayadeth, et al.
Annals of Surgical Oncology|April 16, 2025
ASO Visual Abstract: Use of Risk-Prediction Models (RPMs) for Clinical Decision Making in Soft-Tissue Sarcomas in the Extremities (eSTS): A Survey StudyAnouk A Kruiswijk, Lisa A E Vlug, Ibtissam Acem, et al.
Pageof 26